Pancreatitis, AcuteNCT00490386
Helicobacter Pylori and Acute Alcohol Induced Pancreatitis
An observational study of Pancreatitis, Acute and Helicobacter Infections, run by Tampere University at 1 site in Finland.
Trial summary
This study is performed to measure wether Helicobacter Pylori has an effect on the incidence and course of acute alcohol induced pancreatitis Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Pancreatitis, Acute, Helicobacter Infections
- How many people
- 100 participants
- Where
- 1 siteFinland
- Study dates
- Jun 2006to not given
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Acute alcohol pancreatitis (first)
Who cannot join
- Death during hospitalization
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Alkoholihaimatulehduksen Uusiminen
This study is performed to measure wether Helicobacter Pylori has an effect on the incidence and course of acute alcohol induced pancreatitis
Read the detailed description
A recent pilot study unexpectedly discovered, that Helicobacter pylori infection was rare in patients having their first acute alcohol induced pancreatitis (AAIP) when compared to subjects with similar alcohol use but no history of pancreatitis. This subject has not been studied in humans until now. Therefore we seek to study, with a larger material, wether AAIP is associated with lower prevalence of Helicobacter pylori, by measuring the antibodies against Helicobacter pylori from the sera of AAIP patients and from a control group of alcoholics with no history of AAIP.
- Conditions
- Pancreatitis, Acute, Helicobacter Infections
- Keywords
- Retrospective, Length of Stay, Helicobacter pylori
- Medical subject headings
- Pancreatitis, Helicobacter Infections
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jun 2007 (estimated)
- Study startJun 2006
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Pancreatitis, AcuteStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Defined population
- Time perspective
- Other
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Tampere University
- Sponsor type
- University, hospital or other
- Investigators
- Jahangir A Khan, MS, Principal investigator, Department of Gastroenterology and Alimentary Tract Surgery, Tampere UniversityIsto Nordback, MD, Study director, 1Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00490386
- Sponsor's protocol ID
- R00126-1
- Status last verified
- Jun 2007
- First submitted
- 20 Jun 2007
- Last updated
- 22 Jun 2007
- Results posted
- No
- Data monitoring committee
- No
Publications
Pelli H, Herzig KH, Uotila S, Raty S, Laine S, Sand J, Nordback I. Duodenal diazepam-binding protein expression and plasma cholecystokinin after alcoholic pancreatitis. Scand J Clin Lab Invest. 2006;66(8):677-83. doi: 10.1080/00365510600930918.
PubMed 17101560
Study at a glance
From the registry record, last updated by the sponsor on 22 Jun 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Alkoholihaimatulehduksen Uusiminen
- ClinicalTrials.gov ID
- NCT00490386
- Acronym / sponsor ID
- R00126-1
- Conditions
- Pancreatitis, Acute, Helicobacter Infections
- Keywords
- Retrospective, Length of Stay, Helicobacter pylori
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Tampere UniversityUniversity, hospital or other
- Study start
- Jun 2006
- First posted
- 22 Jun 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is performed to measure wether Helicobacter Pylori has an effect on the incidence and course of acute alcohol induced pancreatitis
Detailed description
A recent pilot study unexpectedly discovered, that Helicobacter pylori infection was rare in patients having their first acute alcohol induced pancreatitis (AAIP) when compared to subjects with similar alcohol use but no history of pancreatitis. This subject has not been studied in humans until now. Therefore we seek to study, with a larger material, wether AAIP is associated with lower prevalence of Helicobacter pylori, by measuring the antibodies against Helicobacter pylori from the sera of AAIP patients and from a control group of alcoholics with no history of AAIP.
Study design
- Observational model
- Defined population
- Time perspective
- Other
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Acute alcohol pancreatitis (first)
Key exclusion criteria (1 listed)
- Death during hospitalization
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jun 2007.
- Background: PubMed 17101560Pelli H, Herzig KH, Uotila S, Raty S, Laine S, Sand J, Nordback I. Duodenal diazepam-binding protein expression and plasma cholecystokinin after alcoholic pancreatitis. Scand J Clin Lab Invest. 2006;66(8):677-83. doi: 10.1080/00365510600930918.
Related trials for Pancreatitis, Acute
Recruiting
Efferon LPS Hemoadsorption in Patients With Acute Pancreatitis
Pancreatitis, Acute
Recruiting
Timing of CHolecystectomy In Severe PAncreatitis
Acute Pancreatitis, Cholelithiasis
Not yet recruiting
Cold Water Papillary Irrigation Plus Rectal NSAIDs vs Rectal NSAIDs Alone for Post-ERCP Pancreatitis (COLD)
Post ERCP Pancreatitis, Acute Pancreatitis (AP)
RecruitingObservational study
CytOSorb TreatMent Of Critically Ill PatientS Registry
Septic Shock, Acute Respiratory Distress Syndrome
RecruitingPhase 1/2
Soy Tomato Juice to Improve Outcomes in Pancreatitis
Recurrent Acute Pancreatitis, Chronic Pancreatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jahangir A Khan, MS principal investigator
Department of Gastroenterology and Alimentary Tract Surgery, Tampere University
Isto Nordback, MD study director
1Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pancreatitis, Acute and Helicobacter Infections, run by Tampere University at 1 site in Finland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Jun 2007. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00490386, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2007; AzTrials last refreshed its copy on 7 Nov 2026.